Should Routine Eye Examinations Be Included in Treatment Bundles for Patients with Candidemia?
J Infect Dis
.
2021 Nov 16;224(9):1626-1627.
doi: 10.1093/infdis/jiab182.
Authors
H Russell Day
1
,
John B Bond
1
,
Bhaskar Gupta
2
,
Kordo Saeed
3
,
Mark P Breazzano
4
Affiliations
1
Department of Ophthalmology and Visual Sciences, Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
2
Ophthalmology Department, Southampton University Hospitals NHS Foundation Trust, Southampton, United Kingdom.
3
Microbiology Department, Southampton University Hospitals NHS Foundation Trust, Southampton, United Kingdom.
4
Wilmer Eye Institute, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
PMID:
33822105
DOI:
10.1093/infdis/jiab182
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antifungal Agents / therapeutic use
Candidemia* / diagnosis
Candidemia* / drug therapy
Humans
Risk Factors
Substances
Antifungal Agents